广州华研精密机械股份有限公司 2022 年第三季度报告 证券代码：301138 证券简称：华研精机 公告编号：2022-047 广州华研精密机械股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 □是 否 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 1 广州华研精密机械股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 122,500,413.60 | -9.6 ...

证券代码：301138 证券简称：华研精机 公告编号：2022-044 广州华研精密机械股份有限公司 关于参加2022年广东辖区上市公司投资者网上集体 接待日活动的公告 本公司及董事会全体成员保证本公告内容的真实、准确和完整、没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的沟通交流，广州华研精密机械股份有限公司（以下 简称"公司"）将参加由广东证监局和广东上市公司协会共同举办的"2022 年广 东上市公司投资者网上集体接待日活动"。现将有关事项公告如下： 本次投资者网上集体接待日活动将通过深圳市全景网络有限公司提供的网 上平台举行，投资者可以登录"全景·路演天下"（http://rs.p5w.net）参与 公司本次投资者网上接待日活动。网上互动交流时间为 2022 年 9 月 22 日（星期 四）下午 15:50-16:50。 届时公司董事、副总经理、董事会秘书、财务总监李敏怡女士，证券事务代 表、董事会办公室经理阮长柏先生将通过网络在线方式与投资者就公司治理、经 营情况及发展战略等问题进行沟通与交流，欢迎广大投资者积极参与。 特此公告。 广州华研精密机械股份有限公司 2022 年 9 月 21 ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥237,964,322.58, a decrease of 3.79% compared to ¥247,326,456.35 in the same period last year[20]. - The net profit attributable to shareholders was ¥38,178,949.52, down 14.13% from ¥44,460,041.41 year-on-year[20]. - The net profit after deducting non-recurring gains and losses was ¥29,339,624.39, a decline of 34.56% compared to ¥44,836,937.79 in the previous year[20]. - The net cash flow from operating activities was negative at -¥1,484,146.57, a significant drop of 102.35% from ¥63,089,987.37 in the same period last year[20]. - Basic earnings per share decreased by 34.69% to ¥0.32 from ¥0.49 in the previous year[20]. - The weighted average return on net assets was 3.43%, down 9.40% from 12.83% in the same period last year[20]. - Total assets at the end of the reporting period were ¥1,404,844,048.35, a decrease of 1.91% from ¥1,432,130,251.30 at the end of the previous year[20]. - The net assets attributable to shareholders were ¥1,091,672,655.74, a slight decrease of 0.73% from ¥1,099,743,803.60 at the end of the previous year[20]. - The gross profit margin for specialized equipment manufacturing was 39.23%, down 6.15% year-on-year[45]. - The company reported a net profit margin of approximately 10.0% for the first half of 2022, down from 12.0% in the same period of 2021[145]. Cash Flow and Investments - The company reported a significant increase of 1,462.31% in cash flow from financing activities, primarily due to dividend payments during the reporting period[44]. - The company reported a cash dividend of 24 million RMB, distributing 2 RMB per 10 shares, with a total of 120 million shares as the base[81]. - The cash dividend accounted for 100% of the distributable profit of approximately 177.59 million RMB[81]. - The company reported a net cash flow from financing activities of -54,430,005.20 yuan, compared to -3,483,935.69 yuan in the previous year[154]. - The ending balance of cash and cash equivalents was 635,483,089.98 yuan, down from 100,285,514.43 yuan at the end of the first half of 2021[154]. - The total cash outflow from operating activities was 295,042,165.48 yuan, an increase from 222,285,737.73 yuan in the previous year[152]. - The company received 1,592,360,597.30 yuan from investment recoveries, a significant rise from 166,447,500.00 yuan in the first half of 2021[155]. Research and Development - Research and development investment rose by 19.74% to ¥12,923,133.69, up from ¥10,792,472.08 in the previous year[44]. - The company achieved a breakthrough in the design and manufacturing of a 176-cavity bottle preform intelligent molding system, enhancing production efficiency[38]. - The company holds a total of 126 patents, including 13 invention patents and 110 utility model patents, reflecting its strong R&D capabilities[39]. - The company is focusing on enhancing its R&D capabilities to meet increasing customer demands for PET container injection molding systems[71]. - The company has allocated 7.8% of its total revenue towards research and development initiatives to enhance product offerings[164]. Market and Product Development - The company has expanded the application of PET preforms to dairy, pharmaceutical, and alcoholic beverage industries, indicating a diversification in market reach[35]. - The company plans to expand its market presence in Southeast Asia, targeting a 20% market share by 2025[160]. - New product launches are expected to contribute an additional 200 million CNY in revenue by the end of 2023[161]. - The company plans to complete the investment projects by 2024, including the intelligent bottle preform forming system and high-speed multi-cavity mold expansion, with total committed investments of RMB 30,606 million[57]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product portfolio[162]. Risk Management and Compliance - The company has outlined potential risk factors and countermeasures in the report, emphasizing the importance of risk awareness for investors[4]. - The company maintained a governance structure compliant with relevant laws and regulations, enhancing shareholder and creditor rights[87]. - There were no significant environmental violations or penalties reported during the period, and the company adhered to environmental protection regulations[86]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties during the reporting period[97]. - The company did not engage in any illegal external guarantees during the reporting period[98]. Shareholder Information - The company has a total of 120,000,000 shares outstanding, with 100% ownership by shareholders[120]. - Major shareholders include Bao Lin with 34,293,240 shares and Wen Shixu with 34,293,240 shares, both subject to lock-up until December 15, 2024[122]. - The total number of shareholders and their respective holdings has not been disclosed in the report[124]. - The company has not reported any share repurchase progress or other significant changes in shareholding structure during the reporting period[120]. Financial Reporting and Audit - The company's semi-annual report for 2022 has not been audited[101]. - The financial statements were approved by the board of directors on August 25, 2022, and reflect the company's financial position accurately[173]. - The company has no significant doubts regarding its ability to continue as a going concern for the next 12 months[175].

Financial Performance - The company's revenue for Q1 2022 was ¥101,535,538.32, a decrease of 16.96% compared to ¥122,270,069.89 in the same period last year[3] - Net profit attributable to shareholders was ¥13,427,472.40, down 30.84% from ¥19,416,055.21 year-on-year[3] - The total operating revenue for Q1 2022 was CNY 121,784,786.83, compared to CNY 170,181,304.89 in Q1 2021, indicating a decline of 28.4%[21] - The total comprehensive income for Q1 2022 was CNY 13,355,798.25, down from CNY 19,654,307.13 in the same period last year, reflecting a decline of 32.1%[20] - The operating profit for Q1 2022 was CNY 16,345,654.99, compared to CNY 23,671,491.07 in Q1 2021, representing a decrease of 30.9%[19] Cash Flow and Assets - The net cash flow from operating activities was -¥30,389,376.79, a decline of 145.91% compared to ¥66,199,015.57 in Q1 2021[3] - Cash flow from operating activities for Q1 2022 showed a net outflow of CNY 30,389,376.79, contrasting with a net inflow of CNY 66,199,015.57 in Q1 2021[23] - The company's cash and cash equivalents at the end of Q1 2022 were CNY 867,377,789.14, a decrease from CNY 893,360,623.30 at the beginning of the year[13] - Cash and cash equivalents at the end of Q1 2022 totaled CNY 863,777,789.14, down from CNY 149,647,269.33 at the end of Q1 2021[24] Costs and Profitability - The total operating costs for Q1 2022 were CNY 88,650,105.08, down from CNY 99,421,599.14, reflecting a cost reduction strategy[17] - The gross profit margin for Q1 2022 was approximately 13.4%, compared to 10.5% in Q1 2021, indicating improved profitability[17] - The company incurred a credit impairment loss of CNY -790,777.26 in Q1 2022, compared to a gain of CNY 195,240.66 in Q1 2021[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 26,049[10] - Basic and diluted earnings per share were both ¥0.11, representing a 50% decrease from ¥0.22 in the previous year[3] - The basic and diluted earnings per share for Q1 2022 were both CNY 0.11, down from CNY 0.22 in Q1 2021[20] Government Support and Investments - Government subsidies recognized in the current period amounted to ¥3,062,709.45, a significant increase of 9206.23% compared to ¥32,910.33 in the previous year[7] - Investment income from financial assets was ¥1,466,948.42, an increase of 943.98% from ¥140,515.06 year-on-year[7] Liabilities and Equity - The total liabilities decreased to CNY 300,376,479.98 from CNY 319,192,551.57, reflecting a reduction in financial obligations[15] - The company's weighted average return on equity was 1.21%, down 4.60% from 5.81% in the same period last year[3] Future Plans - The company plans to focus on new product development and market expansion strategies in the upcoming quarters[17]

Financial Performance - The company's operating revenue for 2021 was ¥558,703,416.19, representing a 6.96% increase from ¥522,354,951.32 in 2020[16]. - The net profit attributable to shareholders for 2021 was ¥98,555,162.01, a 25.42% increase compared to ¥78,581,022.48 in 2020[16]. - The net cash flow from operating activities reached ¥140,747,336.39, showing a significant increase of 100.98% from ¥70,031,137.29 in 2020[16]. - The total assets at the end of 2021 amounted to ¥1,432,130,251.30, a 144.13% increase from ¥586,614,831.68 at the end of 2020[16]. - The net assets attributable to shareholders increased by 237.86% to ¥1,099,743,803.60 at the end of 2021 from ¥325,506,161.41 at the end of 2020[16]. - The basic earnings per share for 2021 was ¥1.1, reflecting a 26.44% increase from ¥0.87 in 2020[16]. - The company reported a quarterly revenue of ¥175,836,756.74 in Q4 2021, the highest among the four quarters[18]. - In 2021, the company achieved a total revenue of 558.70 million yuan, representing a year-on-year growth of 6.96%[41]. - The company's net profit for 2021 was 102.40 million yuan, an increase of 24.45% compared to the previous year[41]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 4.00 RMB per 10 shares (including tax) to all shareholders, based on a total share capital of 120,000,000 shares[4]. - The company reported a cash dividend of 48,000,000.00 CNY, which represents 100% of the distributable profit[127]. - The total distributable profit for the year was 208,351,686.42 CNY, with no stock bonus shares issued[127]. - The company did not propose any cash dividend distribution plan during the reporting period despite having positive distributable profits[127]. - The company has a total of 35,255 shareholders, with significant holdings by individuals such as Bao Helin and Wen Shixu, each holding 28.58%[182]. Corporate Governance - The company has established independent decision-making and supervisory bodies, including a shareholders' meeting, board of directors, and supervisory board, ensuring no institutional confusion with controlling shareholders[98]. - The board of directors consists of seven members, including three independent directors, ensuring a structured governance framework[94]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations[97]. - The company has a dedicated investor relations management system to enhance communication and transparency with investors[96]. - The company has been expanding its board with independent directors to enhance governance and oversight[110]. - The company has a structured remuneration decision-making process based on performance evaluations and market standards[111]. Research and Development - The company holds a total of 105 patents, including 11 invention patents and 91 utility model patents[37]. - Research and development investment for 2021 was 25.19 million yuan, accounting for 4.51% of total revenue[41]. - The company has achieved a production cycle and efficiency for bottle preform equipment that is close to international leading levels, with the capability to design and manufacture molds with up to 176 cavities[35]. - The company has successfully developed a rotary wind tunnel secondary cooling system, which is expected to shorten the preform molding cycle and improve product competitiveness[56]. - The company has initiated the development of a fully automated preform conveying and self-loading system, which is expected to enhance the efficiency of the preform handling process[56]. Market Position and Strategy - The company is positioned in the bottle preform molding equipment industry, which is evolving towards integration, platformization, and automation[26]. - The company’s main products align with national policies promoting smart manufacturing and Industry 4.0, indicating future growth potential[26]. - The company aims to enhance the performance of its products in terms of intelligence, molding cycle, production efficiency, energy conservation, and system stability[85]. - The company targets Southeast Asia, South Asia, and Africa for international market expansion, focusing on countries with high population density and water/milk consumption[87]. - The company plans to enhance its product offerings by focusing on multi-layer barrier packaging technology and intelligent equipment upgrades[42]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements related to development strategies and future plans[4]. - The company’s management discusses potential risks and countermeasures in the annual report, highlighting its proactive approach to risk management[4]. - The company has established a strict supplier management system, ensuring quality control and cost management through dual sourcing for critical materials[31]. Environmental and Social Responsibility - The company has implemented necessary environmental protection measures and facilities to ensure compliance with pollution discharge standards[134]. - The company has developed emergency response plans for environmental incidents and has filed risk assessment reports with local ecological authorities[135]. - The company emphasizes the importance of social responsibility as part of its sustainable development strategy[136]. Financial Management - The company reported a net cash flow from financing activities of ¥659,979,479.75 in 2021, a substantial increase of 2,546.70% compared to -¥26,974,249.73 in 2020, mainly due to funds raised from the IPO[63]. - The total cash and cash equivalents increased by ¥771,880,741.90 in 2021, a remarkable growth of 2,379.34% from ¥31,132,511.88 in 2020[60]. - The company has a total of CNY 39.60 million in construction in progress for the R&D center project[67]. - The company has a total of 70,453.65 million RMB in actual balance of raised funds, including net interest income after deducting bank fees[77]. Employee Information - The company had a total of 675 employees at the end of the reporting period, with 536 in the parent company and 139 in major subsidiaries[122]. - The employee composition includes 389 production personnel, 39 sales personnel, 77 technical personnel, 20 financial personnel, and 150 administrative personnel[122]. - The educational background of employees shows 2 with master's degrees or above, 83 with bachelor's degrees, 148 with associate degrees, and 442 with below associate degrees[123]. Compliance and Legal Matters - The audit opinion for the financial statements was a standard unqualified opinion, issued on April 18, 2022[194]. - The company has maintained a good integrity status with no unfulfilled court judgments or significant overdue debts[159]. - The company has not engaged in any significant related party transactions during the reporting period[160]. - The company has not experienced any bankruptcy restructuring during the reporting period[158].

Financial Performance - The company's operating revenue for 2021 was ¥558,703,416.19, representing a 6.96% increase compared to ¥522,354,951.32 in 2020[16]. - The net profit attributable to shareholders for 2021 was ¥98,555,162.01, a 25.42% increase from ¥78,581,022.48 in 2020[16]. - The net cash flow from operating activities reached ¥140,747,336.39, showing a significant increase of 100.98% compared to ¥70,031,137.29 in 2020[16]. - The total assets at the end of 2021 amounted to ¥1,432,130,251.30, a 144.13% increase from ¥586,614,831.68 at the end of 2020[16]. - The net assets attributable to shareholders increased by 237.86% to ¥1,099,743,803.60 at the end of 2021 from ¥325,506,161.41 at the end of 2020[16]. - The basic earnings per share for 2021 was ¥1.1, up 26.44% from ¥0.87 in 2020[16]. - The company reported a quarterly revenue of ¥175,836,756.74 in Q4 2021, the highest among the four quarters[18]. - In 2021, the company achieved a revenue of CNY 55,870.34 million, representing a year-on-year growth of 6.96%[41]. - The net profit for 2021 was CNY 10,240.31 million, an increase of 24.45% compared to the previous year[41]. - The company's total operating revenue for 2021 was approximately ¥558,000,000, reflecting a year-on-year increase of 10.29%[45]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 4.00 RMB per 10 shares (including tax) to all shareholders, based on a total share capital of 120,000,000 shares[4]. - The total distributable profit for the company was reported at 208,351,686.42 CNY, indicating a strong profitability position[127]. - The company did not propose any stock bonus or capital reserve transfer to increase share capital during the reporting period[127]. - The company announced a cash dividend of 4.00 CNY per 10 shares, totaling 48,000,000 CNY for the reporting period, which represents 100% of the distributable profit[127]. Research and Development - Research and development expenses amounted to CNY 2,519.15 million, accounting for 4.51% of total revenue[41]. - The company holds a total of 105 patents, including 11 invention patents and 91 utility model patents[37]. - The company has completed the research and development of a new injection molding locking mechanism for five-gallon bottled water preforms, which has resulted in one invention patent and one utility model patent application[56]. - The company has developed a fully automated preform conveying and unloading system, which is expected to improve the automation level of the company's operations[56]. - The company has initiated research on a system for in-mold spraying of preforms, which will automate the spraying process and improve production efficiency[58]. - The company aims to enhance the performance of its products in terms of intelligence, molding cycle, production efficiency, energy conservation, and system stability[85]. - The company is investing 100 million RMB in R&D for new technologies aimed at enhancing production efficiency[106]. Market Position and Strategy - The company is positioned in the bottle preform molding equipment industry, which is evolving towards integration, platformization, and automation[26]. - The company operates in the design, research and development, production, and sales of bottle preform intelligent molding systems and molds, providing customized solutions for downstream manufacturers[27]. - The company has seen a significant increase in its cash flow and profitability, indicating strong operational performance and market demand[16]. - The company aims to expand its overseas market while consolidating its domestic market presence[41]. - The company targets Southeast Asia, South Asia, and Africa for international market expansion, focusing on countries with high population density and water/milk consumption[87]. - The company plans to enhance its product offerings by focusing on multi-layer barrier packaging technology and intelligent equipment upgrades[42]. Governance and Compliance - The company’s financial report is guaranteed to be true, accurate, and complete by its board of directors and senior management[3]. - The company has established an independent financial accounting system and can make independent financial decisions[97]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations, ensuring a complete business system[97]. - The board of directors consists of seven members, including three independent directors, ensuring a structured governance framework[94]. - The company has established a robust internal governance structure to ensure operational independence and compliance with relevant laws and regulations[98]. - The company has committed to various shareholder and management promises, ensuring compliance with regulations regarding stock transfer and management[141]. Environmental and Social Responsibility - The company has committed to environmental protection measures, ensuring compliance with pollution control regulations[134]. - The company conducted regular inspections of wastewater, waste gas, and noise pollution, with all tested items meeting the required standards during the reporting period[136]. - The company emphasizes energy conservation and efficiency improvement in production processes, aiming to reduce carbon emissions and resource consumption[136]. - The company was awarded the "Guangzhou Integrity Demonstration SME" honor in December 2021, highlighting its commitment to product quality and integrity in business operations[137]. Risks and Challenges - The company emphasizes the importance of risk awareness regarding forward-looking statements related to development strategies and future plans[4]. - The COVID-19 pandemic has negatively impacted the company's production and order execution, leading to delays in revenue recognition and sales collection[89]. - The company’s management has outlined potential risk factors and countermeasures in the annual report[4]. Shareholder Information - The company has a total of 35,255 shareholders, with significant holdings by individuals such as Bao Lin and Wen Shixu, each holding 28.58%[182]. - The total shares held by directors and senior management at the beginning of the period amounted to 68,586 shares, with no changes reported[104]. - The company has not reported any other shareholders holding more than 10% of shares during the reporting period[187].